Cleared Traditional

K203079 - MR Conditional Sticky Pad Electrode

K203079 is an FDA 510(k) clearance for MR Conditional Sticky Pad Electrode, manufactured by Rhythmlink International, LLC. The device is a Class 2 Neurology device with product code GXY cleared through the Traditional 510(k) pathway after a 119-day FDA review.

K203079 · Rhythmlink International, LLC · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2021
Decision
119d
Days
Class 2
Risk

K203079 is an FDA 510(k) clearance for the MR Conditional Sticky Pad Electrode. Classified as Electrode, Cutaneous (product code GXY), Class II - Special Controls.

Submitted by Rhythmlink International, LLC (Columbia, US). The FDA issued a Cleared decision on February 9, 2021 after a review of 119 days - within the typical 510(k) review window.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1320 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Rhythmlink International, LLC devices

FDA 510(k) Submission Details - K203079

510(k) Number K203079 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 13, 2020
Decision Date February 09, 2021
Days to Decision 119 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
29d faster than avg
Panel avg: 148d · This submission: 119d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GXY Device Classification - Class 2, Special Controls

Product Code GXY Electrode, Cutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GXY Electrode, Cutaneous

All 187
Devices cleared under the same product code (GXY) and FDA review panel - the closest regulatory comparables to K203079.
BioWave BioWraps
K203158 · Biowave Corporation · Jul 2021
Well-Life Garment Electrodes (GM Series)
K200942 · Well-Life Healthcare Limited · Jun 2021
NeuroCap (Model DEC22)
K202913 · Memory MD, Inc. · Mar 2021
Jiajian Self-Adhesive Electrode
K192568 · Wuxi Jiajian Medical Instrument Co., Ltd. · Feb 2021
BRAINSTREAM Disposable Deep Cup EEG Electrodes
K200540 · Conmed Corporation · Jun 2020
Dr-Ho's Foot Pad Electrode (Models: DHFRE-I, CP-I, CP-II, CP-III)
K190118 · Guangzhou Xinbo Electronic Co., Ltd. · May 2020